Small-Molecule Transcription Factor Inhibitors in Oncology

Write The First Customer Review
Show Synopsis

Oncogenic transcription factors are an increasingly important target for anticancer therapies. Inhibiting these transcription factors could allow tumour cells to be "reprogrammed", leading to apoptosis or differentiation from the malignant phenotype. As the use of kinase inhibitors is gradually declining, transcription factor inhibition is the next hot topic for oncology research and merits much attention. This book highlights recent progress in the development of small-molecule inhibitors of oncogenic transcription factors ...

Customer Reviews

Write a Review


This item doesn't have extra editions

loading
    • eBook Details

    Buy eBook

    eBook iconEPUB eBook
    $209.00
    digital devices

    This is a digital edition of this title.

    See Item Details
    • This is a digital eBook
      Nothing will be shipped to you
    • Works with web browsers and the VitalSource app on all Windows, Mac, Chromebook, Kindle Fire, iOS, and Android devices
    • Most eBooks are returnable within 14 days of purchase
    • Questions? See our eBook FAQ